Literature DB >> 31860035

Changes in Trends in Thyroid Cancer Incidence in the United States, 1992 to 2016.

Ann E Powers1, Andrea R Marcadis2, Mark Lee3, Luc G T Morris2, Jennifer L Marti3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31860035      PMCID： PMC6990659          DOI： 10.1001/jama.2019.18528

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  South Korea's Thyroid-Cancer "Epidemic"--Turning the Tide.

Authors:  Hyeong Sik Ahn; H Gilbert Welch
Journal:  N Engl J Med       Date:  2015-12-10       Impact factor: 91.245

2.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

3.  Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis.

Authors:  Luis Furuya-Kanamori; Katy J L Bell; Justin Clark; Paul Glasziou; Suhail A R Doi
Journal:  J Clin Oncol       Date:  2016-10-20       Impact factor: 44.544

Review 4.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

5.  Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.

Authors:  Hyeyeun Lim; Susan S Devesa; Julie A Sosa; David Check; Cari M Kitahara
Journal:  JAMA       Date:  2017-04-04       Impact factor: 56.272

6.  Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Michael J Barry; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Maureen G Phipps; Michael Silverstein; Melissa A Simon; Albert L Siu; Chien-Wen Tseng
Journal:  JAMA       Date:  2017-05-09       Impact factor: 56.272
  6 in total
  10 in total

1.  Discordance Between the American Thyroid Association and the American College of Radiology Guideline Systems for Thyroid Nodule Biopsy.

Authors:  Eric Kim; Roshini Pudhucode; Herbert Chen; Brenessa Lindeman
Journal:  J Surg Res       Date:  2020-07-01       Impact factor: 2.192

2.  Reversal in Thyroid Cancer Incidence Trends in the United States, 2000-2017.

Authors:  Mark Lee; Ann E Powers; Luc G T Morris; Jennifer L Marti
Journal:  Thyroid       Date:  2020-06-25       Impact factor: 6.568

3.  FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer.

Authors:  Elizabeth S Duke; Amy K Barone; Somak Chatterjee; Pallavi S Mishra-Kalyani; Yuan-Li Shen; Emasenyie Isikwei; Hong Zhao; Youwei Bi; Jiang Liu; Nam Atiqur Rahman; Emily Wearne; John K Leighton; Maritsa Stephenson; Idara Ojofeitimi; Barbara Scepura; Abhilasha Nair; Richard Pazdur; Julia A Beaver; Harpreet Singh
Journal:  Clin Cancer Res       Date:  2022-10-03       Impact factor: 13.801

Review 4.  Notch Signaling in Thyroid Cancer.

Authors:  Rachael Guenter; Zeelu Patel; Herbert Chen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.

Authors:  Yuanbo Xue; Jing Li; Xiubo Lu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

6.  Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features.

Authors:  Gui-You Li; Hai-Long Tan; Pei Chen; Hui-Yu Hu; Mian Liu; Deng-Jie Ou-Yang; Rooh-Afza Khushbu; Deepak Pun; Jin-Dong Li; Zhi-Peng Zhang; Qiong Yang; Peng Huang; Shi Chang
Journal:  Cancer Manag Res       Date:  2020-05-13       Impact factor: 3.989

7.  Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo.

Authors:  Emanuel Peplau; Francesco De Rose; Andreas Eichinger; Sybille Reder; Markus Mittelhäuser; Giorgia Scafetta; Markus Schwaiger; Wolfgang A Weber; Armando Bartolazzi; Calogero D'Alessandria; Arne Skerra
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

8.  Influence of Nomenclature Changes on Trends in Papillary Thyroid Cancer Incidence in the United States, 2000 to 2017.

Authors:  Cari M Kitahara; Julie A Sosa; Meredith S Shiels
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

Review 9.  Statistics and pitfalls of trend analysis in cancer research: a review focused on statistical packages.

Authors:  Jie Xu; Yong Lin; Mu Yang; Lanjing Zhang
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

10.  Risk Factors for Contralateral Occult Carcinoma in Patients With Unilateral Papillary Thyroid Carcinoma: A Retrospective Study and Meta-Analysis.

Authors:  Fan Zhang; Boyuan Zheng; Xiaohui Yu; Xichang Wang; Shiwei Wang; Weiping Teng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.